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Introduction: There is no conclusive agreement on the optimal route or timing of peri-operative amiodarone administration for prevention of 
post operative atrial fibrillation(POAF). We attempted to evaluate if an oral only regimen was as effective in preventing POAF after cardiac surgery, 
in comparison to a regimen that included intravenous (IV) administration also by a network meta-analysis of available data. We also attempted to 
assess if pre-operative administration at least one day prior to surgery was superior to post-operative prophylaxis (at least one day after surgery)-and 
included studies had amiodarone administered from 6 days before to 1 day after cardiac surgery.
Methods: We searched PubMed, EMBASE,and Cochrane Central Register of Controlled Trials’ databases for randomized controlled trials conducted 
between 1990 and 2011 that assessed rates of POAF with amiodarone. The comparator was standard medical therapy.Event rates were compared 
using a forest plot of relative risk using a random effects model (Mantel-Haenszel); and Odd’s ratio was calculated in absence of heterogeneity.
Finally an interaction Odd’s ratio was computed to assess efficacy of an oral only regimen compared to one including intravenous administration. We 
also looked to assess if pre-operative amiodarone was superior to post-op prophylaxis.
Results: Twenty three studies (total N = 3,950) met the inclusion-exclusion criteria. Both regimens of amiodarone improved risk of POAF; oral 
only RR 0.59 (95% CI 0.49-0.70; p<0.01) and regimen including IV RR 0.57(95% CI 0.43-0.75, p<0.01). The interaction Odd’s ratio was 1.17(95% 
CI 0.72-1.89, p=0.533).However, pre-operative amiodarone was successful in prevention of POAF (p<0.01), while post-operative prophylaxis was 
ineffective (p=0.09). Univariate regression revealed that benefit of pre-operative amiodarone was independent of the duration of therapy (p=0.98), 
beyond initiation 1 day prior to surgery.
Conclusions: This systematic review suggests both regimens are effective in prevention of POAF after cardiac surgery and that pre-operative 
amiodarone irrespective of duration was effective in preventing POAF while post-operative administration was not.
